{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:53:15Z","timestamp":1782492795332,"version":"3.54.5"},"reference-count":102,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"unspecified","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006261","name":"Taif University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,4]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Drug-related problems (DRPs), which encompass medication errors (MEs), adverse drug reactions and adverse drug events (ADEs), represent significant challenges in healthcare settings. While medication safety has been extensively studied in hospitals and primary care settings leading to development of improvement strategies, there is limited understanding of these issues within prison healthcare environments. This knowledge gap is concerning given that prisoners often have complex medication needs due to higher rates of chronic physical and mental ill health and substance use disorders compared with the general population. Time in prison presents an opportunity to provide treatment for this socially disadvantaged group, making it an important setting to optimise medication management. This scoping review aimed to understand the nature and frequency of medication safety incidents, their contributory factors and evaluate strategies for enhancing medication safety within prison healthcare environments, where unique institutional constraints and security requirements may impact safe medication use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study conducted a systematic search across six databases to appraise the published literature from 2000 to 2023 (Embase, Medline, PsycINFO, CINAHL Plus, Cochrane and Web of Science), with reporting according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Scoping Review guidelines. Data extraction was completed by one author, with validation of a sample by the other authors. The review included quantitative, qualitative and mixed-methods studies examining DRPs in prison healthcare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The review included 42 studies on medication safety in prison healthcare, comprising epidemiological perspectives (52.4%, n=22\/42), aetiological exploration of DRPs (45.2%, n=19\/42) and intervention evaluation (11.9%, n=5\/42). Studies were predominantly from the USA (30.9%, n=13\/42) and the UK (26.1%, n=11\/42). Most studies focused on infectious disease management (52.3%, n=22\/42), particularly HIV treatments (42.8%, n=18\/42), followed by mental health medications (23.8%, n=10\/42). Non-adherence emerged as the most commonly studied DRP, reported in both epidemiological (68.1%, n=15\/22) and aetiological studies (68.4%, n=13\/19). Contributing factors included medication delivery problems, psychosocial factors, accessibility challenges and conflicts between healthcare delivery and security requirements. Five intervention studies were identified, with two from the USA (40%, n=2\/5). These interventions included those addressing medication non-adherence (40%, n=2\/5) and potentially inappropriate prescribing (20%, n=1\/5), and highlighted the potential efficacy of multidisciplinary and pharmacist-led approaches in addressing medication safety challenges within prison healthcare settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This represents the first comprehensive study to present a narrative report on the existing evidence regarding the epidemiology, aetiology and interventions for medication safety events in prison healthcare. While intervention studies demonstrate promising findings from multidisciplinary and pharmacist-led initiatives, further evidence is needed to address DRPs beyond medication non-adherence, guided by a deeper understanding of their contributory factors. Future studies should target preventable MEs and ADEs, as well as wider health conditions to broaden our understanding of prison-specific contributory factors to develop targeted interventions for this vulnerable population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-103781","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:20:26Z","timestamp":1774282826000},"page":"e103781","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring medication safety in prisons: a scoping review"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9595-6555","authenticated-orcid":false,"given":"Mohammed","family":"Alsuwat","sequence":"first","affiliation":[{"name":"Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, University of Manchester, The University of Manchester Faculty of Biology Medicine and Health, Manchester, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Shaw","sequence":"additional","affiliation":[{"name":"Centre for Mental Health and Safety, Division of Psychology and Mental Health, University of Manchester, The University of Manchester Faculty of Biology Medicine and Health, Manchester, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Neil","family":"Keers","sequence":"additional","affiliation":[{"name":"Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, University of Manchester, The University of Manchester Faculty of Biology Medicine and Health, Manchester, England, UK"},{"name":"NIHR Greater Manchester Patient Safety Research Collaboration, Greater Manchester Academic Health Science Network, Manchester, England, UK"},{"name":"Optimising Outcomes with Medicines (OptiMed) Research Unit, Pennine Care NHS Foundation Trust, Ashton-under-Lyne, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"2026062609363902000_16.3.e103781.1","unstructured":"Fair H , Walmsley R . World prison population list. 14th edn. London: Institute for Crime & Justice Policy Research, 2024."},{"key":"2026062609363902000_16.3.e103781.2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/bmb\/ldy027","article-title":"Mental illness and the provision of mental health services in prisons","volume":"127","author":"Forrester","year":"2018","journal-title":"Br Med Bull"},{"key":"2026062609363902000_16.3.e103781.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7489(03)00128-7"},{"key":"2026062609363902000_16.3.e103781.4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026806","article-title":"Prison cell spatial density and infectious and communicable diseases: a systematic review","volume":"9","author":"Simpson","year":"2019","journal-title":"BMJ Open"},{"key":"2026062609363902000_16.3.e103781.5","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldx052"},{"key":"2026062609363902000_16.3.e103781.6","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2008.144279"},{"key":"2026062609363902000_16.3.e103781.7","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2017-104692"},{"key":"2026062609363902000_16.3.e103781.8","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2011-100083"},{"key":"2026062609363902000_16.3.e103781.9","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2009.184242"},{"key":"2026062609363902000_16.3.e103781.10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S2215-0366(16)30142-0","article-title":"Mental health of prisoners: prevalence, adverse outcomes, and interventions","volume":"3","author":"Fazel","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"2026062609363902000_16.3.e103781.11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ageing\/afy186","article-title":"The prevalence of non-communicable disease in older people in prison: a systematic review and meta-analysis","volume":"48","author":"Munday","year":"2019","journal-title":"Age Ageing"},{"key":"2026062609363902000_16.3.e103781.12","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/S2214-109X(18)30539-4","article-title":"Severe mental illness and substance use disorders in prisoners in low-income and middle-income countries: a systematic review and meta-analysis of prevalence studies","volume":"7","author":"Baranyi","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2026062609363902000_16.3.e103781.13","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/0306624X211058952","article-title":"Collaborative Healthcare in Incarcerated Settings","volume":"67","author":"Tadros","year":"2023","journal-title":"Int J Offender Ther Comp Criminol"},{"key":"2026062609363902000_16.3.e103781.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30469-9"},{"key":"2026062609363902000_16.3.e103781.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1311941"},{"key":"2026062609363902000_16.3.e103781.16","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-011-9614-1"},{"key":"2026062609363902000_16.3.e103781.17","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1353\/hpu.2013.0142","article-title":"The triple aims of correctional health: patient safety, population health, and human rights","volume":"24","author":"MacDonald","year":"2013","journal-title":"J Health Care Poor Underserved"},{"key":"2026062609363902000_16.3.e103781.18","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2011.300374"},{"key":"2026062609363902000_16.3.e103781.19","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301741"},{"key":"2026062609363902000_16.3.e103781.20","first-page":"1386","article-title":"Mismanaged care: exploring the costs and benefits of private vs. public healthcare in correctional facilities","volume":"95","author":"Gelman","year":"2020","journal-title":"N Y Univ Law Rev"},{"key":"2026062609363902000_16.3.e103781.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2019-010206"},{"key":"2026062609363902000_16.3.e103781.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31047-4"},{"key":"2026062609363902000_16.3.e103781.23","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.08030416"},{"key":"2026062609363902000_16.3.e103781.24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5055\/jom.2009.0024","article-title":"Overcoming obstacles to implementing methadone maintenance therapy for prisoners: Implications for policy and practice","volume":"5","author":"McKenzie, MPH","year":"2009","journal-title":"J of Opioid Management"},{"key":"2026062609363902000_16.3.e103781.25","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-023-04850-5","article-title":"Understanding the medication safety challenges for patients with mental illness in primary care: a scoping review","volume":"23","author":"Ayre","year":"2023","journal-title":"BMC Psychiatry"},{"key":"2026062609363902000_16.3.e103781.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019101","article-title":"What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature","volume":"8","author":"Assiri","year":"2018","journal-title":"BMJ Open"},{"key":"2026062609363902000_16.3.e103781.27","first-page":"1533","article-title":"Prevalence, contributing factors, and interventions to reduce medication errors in outpatient and ambulatory settings: a systematic review","volume":"17","author":"Gates","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2026062609363902000_16.3.e103781.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4185","article-title":"Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis","volume":"366","author":"Panagioti","year":"2019","journal-title":"BMJ"},{"key":"2026062609363902000_16.3.e103781.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"2026062609363902000_16.3.e103781.30","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"2026062609363902000_16.3.e103781.31","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-5-69"},{"key":"2026062609363902000_16.3.e103781.32","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000050"},{"key":"2026062609363902000_16.3.e103781.33","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-017-0644-y","article-title":"Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study","volume":"6","author":"Bramer","year":"2017","journal-title":"Syst Rev"},{"key":"2026062609363902000_16.3.e103781.34","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022040-00005"},{"key":"2026062609363902000_16.3.e103781.35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/apc.2006.20.408","article-title":"A pilot study of health beliefs and attitudes concerning measures of antiretroviral adherence among prisoners receiving directly observed antiretroviral therapy","volume":"20","author":"White","year":"2006","journal-title":"AIDS Patient Care STDS"},{"key":"2026062609363902000_16.3.e103781.36","doi-asserted-by":"publisher","DOI":"10.1086\/375076"},{"key":"2026062609363902000_16.3.e103781.37","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.4.1296"},{"key":"2026062609363902000_16.3.e103781.38","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.51.11.1444"},{"key":"2026062609363902000_16.3.e103781.39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s11524-012-9682-x","article-title":"Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco","volume":"89","author":"Saberi","year":"2012","journal-title":"J Urban Health"},{"key":"2026062609363902000_16.3.e103781.40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10461-014-0850-8","article-title":"Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study","volume":"19","author":"White","year":"2015","journal-title":"AIDS Behav"},{"key":"2026062609363902000_16.3.e103781.41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1078345817745334","article-title":"Effectiveness of Single- and Multiple-Tablet Antiretroviral Regimens in Correctional Setting for Treatment-Experienced HIV Patients","volume":"24","author":"Merker","year":"2018","journal-title":"J Correct Health Care"},{"key":"2026062609363902000_16.3.e103781.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jana.2008.05.008"},{"key":"2026062609363902000_16.3.e103781.43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jamaophthalmol.2020.0001","article-title":"Glaucoma care of prison inmates at an academic hospital","volume":"138","author":"Kanu","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"2026062609363902000_16.3.e103781.44","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/ajhp\/58.9.779","article-title":"Impact of automation on pharmacist interventions and medication errors in a correctional health care system","volume":"58","author":"Carmenates","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"2026062609363902000_16.3.e103781.45","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1007\/s10461-012-0320-0","article-title":"Jails as an opportunity to increase engagement in HIV care: findings from an observational cross-sectional study","volume":"17 Suppl 2","author":"Avery","year":"2013","journal-title":"AIDS Behav"},{"key":"2026062609363902000_16.3.e103781.46","doi-asserted-by":"publisher","DOI":"10.1177\/1078345813499307"},{"key":"2026062609363902000_16.3.e103781.47","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4443-z","article-title":"Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations","volume":"19","author":"Cunningham","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2026062609363902000_16.3.e103781.48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275907","article-title":"Exploring the challenges to safer prescribing and medication monitoring in prisons: A qualitative study with health care staff","volume":"17","author":"Magola-Makina","year":"2022","journal-title":"PLoS One"},{"key":"2026062609363902000_16.3.e103781.49","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/bcp.15107","article-title":"Implementing prescribing safety indicators in prisons: A mixed methods study","volume":"88","author":"Abuzour","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2026062609363902000_16.3.e103781.50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1108\/IJPH-01-2019-0004","article-title":"A study of the reasons for prescribing and misuse of gabapentinoids in prison including their co-prescription with opioids and antidepressants","volume":"16","author":"Soni","year":"2019","journal-title":"IJPH"},{"key":"2026062609363902000_16.3.e103781.51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/cbm.2187","article-title":"Evaluation of a framework for safe and appropriate prescribing of psychoactive medications in a UK prison","volume":"31","author":"Bebbington","year":"2021","journal-title":"Crim Behav Ment Health"},{"key":"2026062609363902000_16.3.e103781.52","doi-asserted-by":"publisher","DOI":"10.1177\/01410768231166138"},{"key":"2026062609363902000_16.3.e103781.53","doi-asserted-by":"crossref","first-page":"103515","DOI":"10.1016\/j.drugpo.2021.103515","article-title":"\u201cKeeping a lid on it\u201d: Exploring \u201cproblematisations\u201d of prescribed medication in prisons in the UK","volume":"100","author":"Duke","year":"2022","journal-title":"Int J Drug Policy"},{"key":"2026062609363902000_16.3.e103781.54","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-016-1055-7","article-title":"Prevalence and appropriateness of psychotropic medication prescribing in a nationally representative cross-sectional survey of male and female prisoners in England","volume":"16","author":"Hassan","year":"2016","journal-title":"BMC Psychiatry"},{"key":"2026062609363902000_16.3.e103781.55","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/14789949.2010.509804","article-title":"Prisoners\u2019 experiences of antipsychotic medication: influences on adherence","volume":"22","author":"Mills","year":"2011","journal-title":"J Forens Psychiatry Psychol"},{"key":"2026062609363902000_16.3.e103781.56","doi-asserted-by":"publisher","DOI":"10.1002\/cbm.822"},{"key":"2026062609363902000_16.3.e103781.57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7748\/mhp2008.07.11.10.18.c6612","article-title":"Antipsychotic medication in prisons: satisfaction with and adherence to treatment","volume":"11","author":"Bressington","year":"2008","journal-title":"Mental Health Practice"},{"key":"2026062609363902000_16.3.e103781.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2013.01.012"},{"key":"2026062609363902000_16.3.e103781.59","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx084"},{"key":"2026062609363902000_16.3.e103781.60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/17151635221149712","article-title":"Deprescribing initiative of NSAIDs (DIN): Pharmacist-led interventions for pain management in a federal correctional setting","volume":"156","author":"Dawson","year":"2023","journal-title":"Can Pharm J (Ott)"},{"key":"2026062609363902000_16.3.e103781.61","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir032"},{"key":"2026062609363902000_16.3.e103781.62","doi-asserted-by":"publisher","DOI":"10.1080\/09540120802511869"},{"key":"2026062609363902000_16.3.e103781.63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1155\/2005\/767540","article-title":"Treatment of chronic hepatitis C in Canadian prison inmates","volume":"19","author":"Farley","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"2026062609363902000_16.3.e103781.64","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2005.21.683"},{"key":"2026062609363902000_16.3.e103781.65","doi-asserted-by":"crossref","first-page":"101668","DOI":"10.1016\/j.ijlp.2020.101668","article-title":"Promoting adherence to psychopharmacological treatment among prisoners with mental health problems: Follow-up of a randomized controlled trial","volume":"74","author":"Muela","year":"2021","journal-title":"Int J Law Psychiatry"},{"key":"2026062609363902000_16.3.e103781.66","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12709"},{"key":"2026062609363902000_16.3.e103781.67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1871526516666160616111308","article-title":"Adherence to Antiretroviral Therapy and Tuberculosis Treatment in a Prison of Tehran, Iran","volume":"16","author":"Ahmad Seyed Alinaghi","year":"2016","journal-title":"IDDT"},{"key":"2026062609363902000_16.3.e103781.68","doi-asserted-by":"crossref","DOI":"10.5812\/archcid.57911","article-title":"Barriers to Adherence to Antiretroviral Treatment Among Inmates of a Prison in Tehran, Iran: A Qualitative Study","volume":"13","author":"Farhoudi","year":"2018","journal-title":"Arch Clin Infect Dis"},{"key":"2026062609363902000_16.3.e103781.69","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s10461-018-2344-6","article-title":"Adherence to Antiretroviral Therapy Among Incarcerated Persons with HIV: Associations with Methadone and Perceived Safety","volume":"23","author":"Culbert","year":"2019","journal-title":"AIDS Behav"},{"key":"2026062609363902000_16.3.e103781.70","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s10461-015-1198-4","article-title":"The Influence of Medication Attitudes on Utilization of Antiretroviral Therapy (ART) in Indonesian Prisons","volume":"20","author":"Culbert","year":"2016","journal-title":"AIDS Behav"},{"key":"2026062609363902000_16.3.e103781.71","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.drugpo.2014.01.018","article-title":"Execution of control among \u2018non-compliant\u2019, imprisoned individuals in opioid maintenance treatment","volume":"25","author":"Havnes","year":"2014","journal-title":"Int J Drug Policy"},{"key":"2026062609363902000_16.3.e103781.72","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-021-11499-w","article-title":"Various structural factors influenced early antiretroviral therapy initiation amongst HIV infected prisoners: a qualitative exploration in South Ethiopia","volume":"21","author":"Fuge","year":"2021","journal-title":"BMC Public Health"},{"key":"2026062609363902000_16.3.e103781.73","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-022-00429-4","article-title":"Factors affecting optimal adherence to antiretroviral therapy and viral suppression amongst HIV-infected prisoners in South Ethiopia: a comparative cross-sectional study","volume":"19","author":"Fuge","year":"2022","journal-title":"AIDS Res Ther"},{"key":"2026062609363902000_16.3.e103781.74","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1590\/1982-0194201900073","article-title":"People living with HIV\/AIDS in prison: regular use of antiretroviral therapy","volume":"32","author":"Ravanholi","year":"2019","journal-title":"Acta Paul Enferm"},{"key":"2026062609363902000_16.3.e103781.75","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5588\/ijtld.11.0504","article-title":"Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial","volume":"16","author":"Chan","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026062609363902000_16.3.e103781.76","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2014.880398"},{"key":"2026062609363902000_16.3.e103781.77","doi-asserted-by":"publisher","DOI":"10.1080\/09581596.2016.1156649"},{"key":"2026062609363902000_16.3.e103781.78","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2009.090662"},{"key":"2026062609363902000_16.3.e103781.79","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/dme.13982","article-title":"Interventions to improve insulin prescribing practice for people with diabetes in hospital: a systematic review","volume":"36","author":"Bain","year":"2019","journal-title":"Diabet Med"},{"key":"2026062609363902000_16.3.e103781.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.03.041"},{"key":"2026062609363902000_16.3.e103781.81","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0710-y"},{"key":"2026062609363902000_16.3.e103781.82","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2022.100579","article-title":"Trends in gabapentinoid prescribing in UK primary care using the Clinical Practice Research Datalink: an observational study","volume":"27","author":"Ashworth","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"2026062609363902000_16.3.e103781.83","doi-asserted-by":"publisher","DOI":"10.1080\/01639625.2014.1004035"},{"key":"2026062609363902000_16.3.e103781.84","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000075"},{"key":"2026062609363902000_16.3.e103781.85","unstructured":"Aitchinson KJ , Baldwin DS , Barnes TRE , et al . Use of licensed medicines for unlicensed applications in psychiatric practice. 2nd edn. Royal College of Psychiatrists, 2017:15."},{"key":"2026062609363902000_16.3.e103781.86","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0140-6736(11)61817-5","article-title":"A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis","volume":"379","author":"Avery","year":"2012","journal-title":"The Lancet"},{"key":"2026062609363902000_16.3.e103781.87","doi-asserted-by":"crossref","first-page":"183","DOI":"10.14236\/jhi.v25i3.1015","article-title":"SMASH! The Salford medication safety dashboard","volume":"25","author":"Williams","year":"2018","journal-title":"BMJ Health Care Inform"},{"key":"2026062609363902000_16.3.e103781.88","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-086309","article-title":"Understanding the implementation of a multidisciplinary intervention using a suite of prescribing safety indicators to improve medication safety in prison healthcare settings: a qualitative study","volume":"15","author":"Jeffries","year":"2025","journal-title":"BMJ Open"},{"key":"2026062609363902000_16.3.e103781.89","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.0738"},{"key":"2026062609363902000_16.3.e103781.90","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-085607","article-title":"Understanding the scale and nature of avoidable healthcare-associated harm for prisoners in England: protocol for a retrospective cross-sectional study","volume":"14","author":"Carson-Stevens","year":"2024","journal-title":"BMJ Open"},{"key":"2026062609363902000_16.3.e103781.91","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01774-9","article-title":"Preventable medication harm across health care settings: a systematic review and meta-analysis","volume":"18","author":"Hodkinson","year":"2020","journal-title":"BMC Med"},{"key":"2026062609363902000_16.3.e103781.92","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s11096-023-01626-5","article-title":"Prevalence, contributing factors, and interventions to reduce medication errors in outpatient and ambulatory settings: a systematic review","volume":"45","author":"Naseralallah","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"2026062609363902000_16.3.e103781.93","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-018-2988-y","article-title":"Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy","volume":"18","author":"Lombardi","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"2026062609363902000_16.3.e103781.94","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-015-0137-9"},{"key":"2026062609363902000_16.3.e103781.95","doi-asserted-by":"crossref","DOI":"10.1186\/s12911-021-01584-w","article-title":"Implementation of an Electronic Medication Management System in a large tertiary hospital: a case of qualitative inquiry","volume":"21","author":"Vaghasiya","year":"2021","journal-title":"BMC Med Inform Decis Mak"},{"key":"2026062609363902000_16.3.e103781.96","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0879"},{"key":"2026062609363902000_16.3.e103781.97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2018.11.015"},{"key":"2026062609363902000_16.3.e103781.98","first-page":"700","article-title":"The National Coordinating Council for Medication Error Reporting and Prevention: promoting patient safety and quality through innovation and leadership","volume":"34","author":"Cousins","year":"2008","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"2026062609363902000_16.3.e103781.99","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530010043033"},{"key":"2026062609363902000_16.3.e103781.100","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528100-00003"},{"key":"2026062609363902000_16.3.e103781.101","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afu145"},{"key":"2026062609363902000_16.3.e103781.102","doi-asserted-by":"publisher","DOI":"10.1080\/00140139.2017.1301574"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-103781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:42:05Z","timestamp":1782492125000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-103781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":102,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,23]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjopen-2025-103781"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-103781","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}